Insider · CIK 0001383909
Genevieve Claire Combes
Files at HHS (HARTE HANKS INC). First filing -, latest -.
In brief
Genevieve Claire Combes files SEC Form 4 as director at HHS (HARTE HANKS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Genevieve Claire Combes has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | HHS HARTE HANKS INC | AGrant or award Common Stockindirect: RSU shares held by Harte Hanks, granted to the participant but not yet vested | +27,861 | $3.23 | $90k | 27,861 | Dec 15, 2025 |
| May 29, 2024 | HHS HARTE HANKS INC | AGrant or award Common Stockindirect: RSU shares held by Harte Hanks, granted to the participant but not yet vested | +12,048 | $7.47 | $90k | 12,048 | May 31, 2024 |
Questions about Genevieve Claire Combes
Answered from the filings on this page, as of the latest one.
Is Genevieve Claire Combes buying or selling?
Genevieve Claire Combes has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Genevieve Claire Combes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Genevieve Claire Combes has 0.
Where does Genevieve Claire Combes file Form 4?
Genevieve Claire Combes has filed Form 4 at HHS (HARTE HANKS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.